Publications by authors named "Garrett May"

Claim this Profile
P
Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059.
Jen-Hao Wu, Edoardo Pennesi, Francisco Bautista, May Garrett, Kei Fukuhara

Clin Pharmacokinet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemia.
May Garrett, Beverly Knight, Jorge E Cortes, Michael W Deininger

Cancer Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entropy-Induced Selectivity Switch in Gold Catalysis: Fast Access to Indolo[1,2-a]quinolines.
Robin Heckershoff, Garrett May, Janika Däumer, Lukas Eberle, Petra Krämer

Chemistry· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma.
May Garrett, Ana Ruiz-Garcia, Kourosh Parivar, Brian Hee, Joseph Boni

J Pharmacokinet Pharmacodyn· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of smoking status on axitinib pharmacokinetics in patients with non-small-cell lung cancer.
May Garrett, Timothy Taylor, Diane R Mould, Michael A Amantea, Ying Chen

Cancer Chemother Pharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
Ying Chen, Brian I Rini, Robert J Motzer, Janice P Dutcher, Olivier Rixe, May Garrett

Target Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axitinib plasma pharmacokinetics and ethnic differences.
Ying Chen, Akiyuki Suzuki, Michael A Tortorici, May Garrett, Robert R LaBadie

Invest New Drugs· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of single-agent axitinib across multiple solid tumor types.
Michael A Tortorici, Ezra E W Cohen, Yazdi K Pithavala, May Garrett, Ana Ruiz-Garcia

Cancer Chemother Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic analysis of axitinib in healthy volunteers.
May Garrett, Bill Poland, Meghan Brennan, Brian Hee, Yazdi K Pithavala

Br J Clin Pharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology of axitinib.
Ying Chen, Michael A Tortorici, May Garrett, Brian Hee, Karen J Klamerus

Clin Pharmacokinet· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysis.
Brian I Rini, May Garrett, Bill Poland, Janice P Dutcher, Olivier Rixe

J Clin Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers.
Yazdi K Pithavala, Ying Chen, Melvin Toh, Paulina Selaru, Robert R LaBadie, May Garrett

Cancer Chemother Pharmacol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers.
Yazdi K Pithavala, Warren Tong, Janessa Mount, Sadayappan V Rahavendran, May Garrett

Invest New Drugs· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of sunitinib malate in subjects with hepatic impairment.
Carlo L Bello, May Garrett, Laurie Sherman, John Smeraglia, Bob Ryan

Cancer Chemother Pharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of sunitinib malate in subjects with impaired renal function.
Reza Khosravan, Melvin Toh, May Garrett, Joann La Fargue, Grace Ni

J Clin Pharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interaction between amprenavir and delavirdine: evidence of induced clearance by amprenavir.
Jonathan Q Tran, Carolyn Petersen, May Garrett, Brian Hee, Bradley M Kerr

Clin Pharmacol Ther· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis